AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
ROE: Returns DecliningContracting
Percentile Rank21
3Y CAGR-0.3%
5Y CAGR-8.8%
Year-over-Year Change
Return on equity
3Y CAGR
-0.3%/yr
vs -15.1%/yr prior
5Y CAGR
-8.8%/yr
Recent acceleration
Acceleration
+14.8pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 10.68% | +0.4% |
| 2024 | 10.63% | +48.1% |
| 2023 | 7.18% | -33.4% |
| 2022 | 10.78% | -55.7% |
| 2021 | 24.33% | +43.9% |
| 2020 | 16.91% | -0.7% |
| 2019 | 17.02% | -17.9% |
| 2018 | 20.75% | -15.5% |
| 2017 | 24.56% | -14.4% |
| 2016 | 28.70% | - |